Page last updated: 2024-08-05 10:50:13

indole-3-acetic acids

An indol-3-yl carboxylic acid in which the carboxylic acid specified is acetic acid.

ChEBI ID: 24803

Members (11)

MemberDefinitionRole
2-[1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-3-indolyl]acetic acid methyl ester2-[1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-3-indolyl]acetic acid methyl ester
2-Methylindole-3-acetic acid2-Methylindole-3-acetic acid
2-oxindole-3-acetic acidA member of the class of oxindoles that is 2-oxindole carrying a carboxymethyl substituent at position 3.2-oxindole-3-acetic acid
5-methoxy-methylindoleacetic acidN-Deschlorobenzoyl indomethacin
5-methoxyindoleacetic acidA member of the class of indole-3-acetic acids in which the hydrogen at position 5 of indole-3-acetic acid has been replaced by a methoxy group.5-methoxyindole-3-acetic acid
cinmethacincinmetacin
hydroxyindoleacetic acidA member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.(5-hydroxyindol-3-yl)acetic acid
indole-3-acetic acid ethyl esterEthyl 3-indoleacetate
indoleacetic acidA monocarboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a 1H-indol-3-yl group.indole-3-acetic acid
indomethacinA member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.indometacin
pai 039Tiplasinin

Research

Studies (39,345)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-199018,092 (45.98)18.7374
1990's9,295 (23.62)18.2507
2000's6,111 (15.53)29.6817
2010's4,700 (11.95)24.3611
2020's1,147 (2.92)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials2,175 (5.21%)5.53%
Reviews1,387 (3.32%)6.00%
Case Studies1,571 (3.76%)4.05%
Observational17 (0.04%)0.25%
Other36,584 (87.66%)84.16%